Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Quipt Home Medical Corp QIPT


Primary Symbol: T.QIPT

Healthcare
Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators... see more

Recent & Breaking News (TSX:QIPT)

Sylentis Initiates a Phase III Study for the Treatment of Dry Eye Syndrome

PR Newswire Europe Non Regulatory June 1, 2017

PharmaMar and Eczacıbaşı Sign a Licensing Agreement for Aplidin® in Turkey

PR Newswire Europe Non Regulatory May 25, 2017

Patient Home Monitoring Releases Conference Call Highlighting Financial Q2 FY 2017

MarketWire Canada May 25, 2017

Patient Home Monitoring Releases Second Quarter Financials; Posts Increase in Quarterly Revenues, Gross Profit and Adjusted EBITDA, Reports Positive Net Profit for the Quarter

MarketWire Canada May 24, 2017

Patient Home Monitoring Announces Date and Time for Quarterly Conference Call

MarketWire Canada May 22, 2017

PharmaMar Announces New Data with its Compounds Yondelis® and Lurbinectedin During ASCO 2017

PR Newswire Europe Non Regulatory May 19, 2017

PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for Lurbinectedin Covering Australia, New Zealand and Several Asian Countries

PR Newswire Europe Non Regulatory May 18, 2017

PHM Unaware Of Any Material Change

MarketWire Canada March 13, 2017

Patient Home Monitoring Releases Conference Call Highlighting Financial Q1 FY 2017

MarketWire Canada February 23, 2017

Patient Home Monitoring Posts First Quarter Financials and Conference Call Information

MarketWire Canada February 22, 2017

Patient Home Monitoring Announces Date and Time for Quarterly Conference Call

MarketWire Canada February 21, 2017

Patient Home Monitoring Releases Conference Call Highlighting Year End Financials

MarketWire Canada January 25, 2017

Patient Home Monitoring Posts Year End Financials and Conference Call Information

MarketWire Canada January 24, 2017

Patient Home Monitoring Updates Timing of Proposed Split into Separate Operating Companies: Viemed and Apparo; Provides Impact of Cures Act

MarketWire Canada January 12, 2017

PharmaMar and Chugai Pharmaceutical Enter into a License and Commercialization Agreement for PM1183 in Japan

PR Newswire December 22, 2016

PharmaMar Presents Positive Results With Its Conjugated Antibody MI130110 in CD13-Expressing Tumor-Cells

PR Newswire December 1, 2016

PharmaMar Appoints Pascal Besman as Chief Operating Officer of PharmaMar U.S.

PR Newswire November 16, 2016

PharmaMar Shows New Clinical Data With Yondelis® in Different Sarcoma Subtypes at CTOS 2016

PR Newswire Europe Non Regulatory November 10, 2016

Patient Home Monitoring Highlights Improvements From Fourth Quarter Activities; Updates Timing of Proposed Split into Separate Operating Companies: Viemed and Apparo

MarketWire Canada November 9, 2016

Patient Home Monitoring Announces Appointment of New Chief Financial Officer

MarketWire Canada October 31, 2016